Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

http://www.wikidata.org/entity/Q37723422

about

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease Genetic heterogeneity in Alzheimer disease and implications for treatment strategies Impairment of the nerve growth factor pathway driving amyloid accumulation in cholinergic neurons: the incipit of the Alzheimer's disease story?Detection of subjects and brain regions related to Alzheimer's disease using 3D MRI scans based on eigenbrain and machine learning Identification of plexin A4 as a novel clusterin receptor links two Alzheimer's disease risk genes.Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle.Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.Chronic low-dose-rate ionising radiation affects the hippocampal phosphoproteome in the ApoE-/- Alzheimer's mouse model.Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.Alzheimer's disease: experimental models and reality.Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology.APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.A Case Report of a 37-Year-Old Alzheimer's Disease Patient with Prominent Striatum Amyloid Retention.Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease.Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability.Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice.Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease-like pathology.Lower functional connectivity of default mode network in cognitively normal young adults with mutation of APP, presenilins and APOE ε4.APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes.Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.The Role of KLF in Alzheimer's Disease APOE ε2 is associated with increased tau pathology in primary tauopathy Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review

P2860

Q26827353-95051EF8-F33B-4A31-8E61-AE43022C8E9E Q26995802-AFD6D79F-56D1-49B4-BAD7-0A370F8A0D2E Q28066132-28721702-04F7-404C-B1B5-B669B88F2867 Q29541941-E5890B1C-0B3B-4FF2-A707-144E9DBB9EB3 Q30832877-E99FE84A-FABB-46E8-B49D-FFAB7D9C6AEF Q33817811-426B6B17-9DE7-4DC0-A41D-4B0D6D1B4D46 Q34435017-61C3E59F-7B80-4978-AA31-74C3B0D3D30F Q35810005-D2FFE190-8D89-40A9-86E2-D19FE51C753D Q35947548-DEA5C833-3854-4F2E-B6EC-C77290D19713 Q36615510-B4CFD7F9-B17A-40CC-86A8-C18041DE4F90 Q36758446-C5D8212B-A0B4-4DBE-ABDA-57C4A7528C9A Q37069525-9CF1CB80-41A2-4899-A947-A16A302E25E0 Q37326829-4A62CB0C-C223-4A8E-91D4-11E93C6FEAE0 Q37687720-7269F409-37D9-4125-850A-827CB97754F5 Q38407944-A5DE9E21-04B8-42D1-9654-D9B93D595AB9 Q38930361-BCCD6762-4705-430F-A390-3E26193BEE58 Q39057135-3CA075AF-D485-4C38-A7CE-A46E3815C567 Q39222720-BA856104-7696-4CC9-B80F-829321563FAC Q39281122-BA93E81A-E328-4BB1-A713-E4EDFF25691F Q41010043-E137A45B-7C05-4351-AB97-E746D8517E78 Q41449790-D6D1DD38-C68F-4A61-8134-4DC787E2233C Q41813545-35543802-81BA-42D2-9C01-EF51434746B1 Q42291622-BBEC32A2-6349-49C0-95A9-6F6C548E132D Q45952212-5329AFDF-3484-4C57-8E92-E86D1E17C156 Q46257047-DFB68323-E775-4D9E-9BA9-2843DA6D497A Q47333744-932E57CA-B1CD-4D61-A770-9C1770490926 Q48127496-495DDB37-961A-4499-BBB9-975E0A6598F0 Q48169931-78283897-0966-44AC-9FCE-C63E9638DC74 Q48729885-D28C47AD-9764-4355-9FDB-C557F713DCE8 Q51826580-6937E1BD-AD7F-4FAC-A482-7A7DC7EC4125 Q53395987-3D4ADD7F-7BDA-4674-A858-4A3FE4206B4B Q57299999-E091D045-9529-4A57-B08E-A2BF88D7BD99 Q57804769-E7287AA4-3AE2-4D4D-8705-251057BF0F00 Q58549216-9AC4F7B1-6593-4346-9BD8-87250CB23293

P2860

Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

http://www.wikidata.org/entity/Q37723422

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regional distribution of synap ...... familial Alzheimer's disease.

@en

Regional distribution of synap ...... familial Alzheimer's disease.

@nl

type

label

Regional distribution of synap ...... familial Alzheimer's disease.

@en

Regional distribution of synap ...... familial Alzheimer's disease.

@nl

prefLabel

Regional distribution of synap ...... familial Alzheimer's disease.

@en

Regional distribution of synap ...... familial Alzheimer's disease.

@nl

P1433

Q37723422-1BB737A3-7C91-4F72-A27C-60A96854752A

P1476

Q37723422-FA80EC5C-A7D2-4AC3-991B-D18445788054

P2093

Q37723422-218C8626-D622-498A-8E7B-B342418AF988

Q37723422-AC7BF81A-880E-4063-A202-FB5541C08A1C

Q37723422-B14BE88C-5329-4102-B5E7-D1EA1AE5382A

Q37723422-BC939799-ED4F-41A9-BF54-92B3773A3A99

Q37723422-C04ACCD7-4B41-4D15-9D4D-96EFED109A3A

Q37723422-DAF4DA1C-BB82-4D9F-8BF6-2FD25CF46F6A

Q37723422-E7672EF7-F7CA-464F-A062-DFCD6FBA2BED

Q37723422-EA953D63-865C-4CE7-B793-F0B99959E808

Q37723422-EF29E3E3-5C20-4E34-9649-AE8446F32789

P2860

Q37723422-0B8E2A56-68E2-426D-8051-5516F5CECCBF

Q37723422-0BC40523-AF4F-4069-9BF5-B1BFF05E2480

Q37723422-1C49580B-88BB-4C9D-98F3-D160A25B9142

Q37723422-1D8B1BD9-6AE5-4DDA-980D-EB6C2D0ACC97

Q37723422-1F9664AE-8AE4-4FE9-9145-FB09438E312D

Q37723422-20276752-E327-444A-B8EB-4E430A142CB0

Q37723422-22EDA624-B56D-42D9-AF83-BCA858329574

Q37723422-26616948-8336-4FB9-9578-AC1B022BC5B0

Q37723422-2FEA4C37-B691-49FD-8C47-1427922E6412

Q37723422-3EBDB3C4-011D-4483-AFE3-9049E11FC563

P304

Q37723422-CE35E735-F48E-4A33-BF0C-8D2FAA54ADCB

P31

Q37723422-A5E7E2F9-8BBA-4E55-8E31-122467699EA1

P356

Q37723422-6429F88D-BF54-4541-B81D-01FBE17D58BF

P407

Q37723422-9B28AE96-9030-4F52-96CD-C23F1E5C8CBB

P433

Q37723422-F40510FE-101D-4AC2-A324-600E525ABE4E

P478

Q37723422-ED12B1D9-8A21-4BD5-9ADB-47EC87ACA5DE

P50

Q37723422-2C626BF2-D3EA-4295-AF1A-0F5B673DD7B0

Q37723422-80765B5E-5B95-4802-AE2C-2D6DD4A6AC2B

Q37723422-A08D082E-3ADE-4A09-A107-20062BFDE11A

Q37723422-D146B658-665E-4193-8DF3-BC63FE6521B5

P577

Q37723422-9A123DD6-D4DE-4ABE-AABB-DD9F12D0EA19

P5875

Q37723422-65B7CDD7-BD16-430B-BB0B-1ED1B2E5258D

P698

Q37723422-2327A7F7-9C07-46FD-8F5E-F43450CE5F0B

P921

Q37723422-8D2D6563-9C5A-4F58-B1D6-F6AD36DABF0C

P932

Q37723422-4C2B047B-BE93-4E20-9E9C-DE1EDAA335EE

P356

P1433

P1476

Regional distribution of synap ...... familial Alzheimer's disease.

@en

P2093

Aleksandra Wojtas

http://www.w3.org/2001/XMLSchema#string

Anne Rovelet-Lecrux

http://www.w3.org/2001/XMLSchema#string

Guojun Bu

http://www.w3.org/2001/XMLSchema#string

Joseph E Parisi

http://www.w3.org/2001/XMLSchema#string

Matthew Baker

http://www.w3.org/2001/XMLSchema#string

Mitsuru Shinohara

http://www.w3.org/2001/XMLSchema#string

Neill R Graff-Radford

http://www.w3.org/2001/XMLSchema#string

Pritam Das

http://www.w3.org/2001/XMLSchema#string

Shinsuke Fujioka

http://www.w3.org/2001/XMLSchema#string

P2860

Arc/Arg3.1 regulates an endosomal pathway essential for activity-dependent β-amyloid generation

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition

Neuropathological stageing of Alzheimer-related changes

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

P304

1533-1549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWU046

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 5

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Rosa Rademakers

Dennis W. Dickson

Melissa E. Murray

Ronald C. Petersen

P577

2014-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260808784

http://www.w3.org/2001/XMLSchema#string

P698

24625695

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3999719

http://www.w3.org/2001/XMLSchema#string